Javascript must be enabled to continue!
Siraitia grosvenorii (Swingle) C. Jeffrey: Research Progress of Its Active Components, Pharmacological Effects, and Extraction Methods
View through CrossRef
Siraitia grosvenorii (Swingle) C. Jeffrey, a perennial vine of the Cucurbitaceae family, is a unique medicine food homology species from China. S. grosvenorii can be used as a natural sweetener in the food industry and as a traditional medicine for moistening the lungs, quenching a cough, smoothing the intestines, and relieving constipation. Additionally, the fruits, roots, stems, and leaves of S. grosvenorii are rich in active ingredients, and have pharmacological effects such as immune regulation, hypoglycemia, and antioxidant, hepatoprotective, and antitumor effects, etc. Therefore, S. grosvenorii has broad application prospects in the pharmaceutical industry. This paper reviews the bioactive components, pharmacological effects, and extraction methods of S. grosvenorii, summarizes them, and proposes their future development directions. This current overview highlights the value of S. grosvenorii. By documenting the comprehensive information of S. grosvenorii, the review aims to provide the appropriate guidelines for its future in-depth development and the utilization of S. grosvenorii resources for their roles as active ingredient (triterpenoids, flavonoids, and polysaccharides, etc.) sources in the food industry and in the development of functional foods.
Title: Siraitia grosvenorii (Swingle) C. Jeffrey: Research Progress of Its Active Components, Pharmacological Effects, and Extraction Methods
Description:
Siraitia grosvenorii (Swingle) C.
Jeffrey, a perennial vine of the Cucurbitaceae family, is a unique medicine food homology species from China.
S.
grosvenorii can be used as a natural sweetener in the food industry and as a traditional medicine for moistening the lungs, quenching a cough, smoothing the intestines, and relieving constipation.
Additionally, the fruits, roots, stems, and leaves of S.
grosvenorii are rich in active ingredients, and have pharmacological effects such as immune regulation, hypoglycemia, and antioxidant, hepatoprotective, and antitumor effects, etc.
Therefore, S.
grosvenorii has broad application prospects in the pharmaceutical industry.
This paper reviews the bioactive components, pharmacological effects, and extraction methods of S.
grosvenorii, summarizes them, and proposes their future development directions.
This current overview highlights the value of S.
grosvenorii.
By documenting the comprehensive information of S.
grosvenorii, the review aims to provide the appropriate guidelines for its future in-depth development and the utilization of S.
grosvenorii resources for their roles as active ingredient (triterpenoids, flavonoids, and polysaccharides, etc.
) sources in the food industry and in the development of functional foods.
Related Results
Current Insight on Siraitia grosvenorii Flavonoids Extraction Process and its Bioactivity Characteristic: A Review
Current Insight on Siraitia grosvenorii Flavonoids Extraction Process and its Bioactivity Characteristic: A Review
The Siraitia grosvenorii is a Chinese herb with various bioactive properties that has been widely used as a culinary ingredient and in traditional medicine. Flavonoids are among th...
Assessment of suitable habitats and quality of Siraitia grosvenorii in China
Assessment of suitable habitats and quality of Siraitia grosvenorii in China
Climate change impacts the habitats of medicinal plants and potentially
affects the quality of herbal medicines. Siraitia grosvenorii, a crucial
medicinal and edible traditional Ch...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
Optimization of Extraction Conditions of Active Constituents from Siraitia Grosvenorii
Optimization of Extraction Conditions of Active Constituents from Siraitia Grosvenorii
The conditions of cascade extraction and isolation of some active constituents from Siraitia grosvenorii were optimized. The active constituents were extracted by ultrasonic extrac...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Developmental and Molecular Insights into AgNO3-Induced Partial Masculinization and Stamen Abortion in Siraitia grosvenorii C. Jeffrey ex A.M. Lu and Zhi Y. Zhang
Developmental and Molecular Insights into AgNO3-Induced Partial Masculinization and Stamen Abortion in Siraitia grosvenorii C. Jeffrey ex A.M. Lu and Zhi Y. Zhang
This study focuses on Siraitia grosvenorii, an economically important crop endemic to Guangxi Province, China, with significant value in both the pharmaceutical and food industries...
STUDY OF THE CHEMICAL COMPOSITION AND BIOACTIVITY OF TEA BAGS FROM Cordyceps militaris, Siraitia grosvenorii AND Chrysanthemum sinense
STUDY OF THE CHEMICAL COMPOSITION AND BIOACTIVITY OF TEA BAGS FROM Cordyceps militaris, Siraitia grosvenorii AND Chrysanthemum sinense
Nghiên cứu này tiến hành thử nghiệm phối trộn ba loại dược liệu truyền thống là Đông trùng Hạ thảo (Cordyceps militaris), La hán quả (Siraitia grosvenorii) và Hoa cúc (Chrysanthemu...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...

